Skip to main content
DNA Labs India

OTOA Gene Deafness, autosomal recessive type 22 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

OTOA Gene Deafness, autosomal recessive type 22 NGS Genetic Test

Short Name: OTOA Genetic Test

Also known as: DFNB22, OTOA-related hearing loss

OTOA Gene Deafness, autosomal recessive type 22 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Results are typically available within 3 to 4 weeks after sample collection.. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

To identify mutations in the OTOA gene associated with autosomal recessive deafness type 22 (DFNB22), aiding in accurate diagnosis, genetic counseling, and management of hereditary hearing loss.

Test Code
2327
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Results are typically available within 3 to 4 weeks after sample collection.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

A genetic counseling session is recommended to discuss clinical history and family pedigree. No specific preparation like fasting is required, but avoid contaminants on the sample collection site.

Method: Venipuncture or FTA card application

Step 2

Laboratory Analysis

Standard blood draw from a vein using a sterile needle or application of a blood drop on an FTA card, following aseptic techniques.

Step 3

Report Delivery

The sample is labeled, stored at ambient temperature, and transported to the laboratory for DNA extraction and NGS sequencing.

Timeline: Results are typically available within 3 to 4 weeks after sample collection.

Patient Instructions

1
Before the Test:Genetic counseling session to review clinical history and draw a family pedigree chart. No dietary restrictions or special preparation needed.
2
During the Test:Blood sample collection via venipuncture or FTA card, followed by DNA extraction and NGS sequencing in the laboratory.
3
After the Test:Results are analyzed by geneticists and delivered in a comprehensive report. Post-test counseling is available for interpretation.

About This Test

Who Should Get This Test

To identify mutations in the OTOA gene associated with autosomal recessive deafness type 22 (DFNB22), aiding in accurate diagnosis, genetic counseling, and management of hereditary hearing loss.

How to Prepare

  • Fasting is not required for this test
  • Provide detailed clinical and family history during pre-test counseling
  • Ensure proper labeling of the sample to avoid mix-ups
  • Use the provided collection kit for home sample collection

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"This test is essential for diagnosing hereditary hearing loss in families, enabling early intervention and genetic counseling for affected individuals."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume5 ml blood
ContainerEDTA tube or FTA card
Collection MethodVenipuncture or FTA card application

Sample Stability

Blood sample stable for 48 hours at room temperature (15-30°C)
Extracted DNA stable for up to 6 months when stored at -20°C
Sample Rejection Criteria:
  • Hemolyzed or clotted blood samples
  • Insufficient sample volume
  • Improperly labeled or contaminated samples

Understanding Your Results

Results indicate the presence or absence of pathogenic variants in the OTOA gene, which are associated with autosomal recessive deafness type 22. Genetic counseling is essential for accurate interpretation.
📊

Pathogenic variant detected

Confirms a diagnosis of OTOA gene deafness. Genetic counseling recommended for family planning and management options such as hearing aids or cochlear implants.

📊

No pathogenic variant detected

Unlikely to have OTOA gene deafness; consider other genetic or environmental causes of hearing loss. Further clinical evaluation may be needed.

📊

Variant of uncertain significance

The identified variant's clinical impact is unclear. Additional testing, family studies, or clinical follow-up is advised.

⚠️ When to Consult a Doctor:

If you experience symptoms of hearing loss, have a family history of deafness, or if genetic testing is recommended by a healthcare provider. Early consultation allows for timely diagnosis and intervention.

Limitations

  • May not detect all types of genetic variants (e.g., large deletions)
  • Results require clinical correlation and genetic counseling
  • Limited to mutations in the OTOA gene; other causes of deafness may not be identified

Risks & Considerations

  • Minimal risk from blood draw, such as bruising or discomfort
  • Potential psychological impact from genetic diagnosis
  • Risk of incidental findings or variants of uncertain significance

Interfering Factors

  • Poor sample quality or contamination
  • DNA degradation due to improper storage
  • Technical errors in sequencing

Compare With Similar Tests

TestOTOA Gene Deafness, autosomal recessive type 22 NGS Genetic TestGJB2 Gene Deafness NGS Genetic TestSLC26A4 Gene Deafness NGS Genetic TestTMC1 Gene Deafness Genetic TestComprehensive Hearing Loss Gene Panel
ComparisonOTOA Gene Deafness, autosomal recessive type 22 NGS Genetic Test

Frequently Asked Questions

What is OTOA gene deafness?
OTOA gene deafness is a genetic disorder caused by mutations in the OTOA gene, leading to autosomal recessive deafness type 22 (DFNB22), which affects hearing from birth or early childhood.
How is OTOA gene deafness inherited?
It is inherited in an autosomal recessive pattern, meaning a person must inherit two mutated copies of the OTOA gene (one from each parent) to develop the condition.
What are the common symptoms of OTOA gene deafness?
Symptoms include difficulty hearing normal-volume sounds, trouble understanding speech in noisy environments, frequent ear infections, tinnitus, and vertigo.
How is OTOA gene deafness diagnosed?
Diagnosis involves hearing tests (audiograms) and genetic testing, such as NGS sequencing, to detect mutations in the OTOA gene.
What is NGS genetic testing?
Next-Generation Sequencing (NGS) is a advanced method that sequences multiple genes simultaneously, providing efficient and accurate diagnosis for genetic disorders like OTOA gene deafness.
What is the cost of the OTOA gene test in India?
The cost of the OTOA Gene Deafness NGS Genetic Test at DNA Labs India is INR 20,000, with potential discounts for online bookings.
Is home sample collection available for this test?
Yes, DNA Labs India offers free home sample collection for online bookings across numerous cities in India for convenience.
How long does it take to get the test results?
Results are typically available within 3 to 4 weeks after sample collection, delivered via online portal, email, or WhatsApp.
Is the OTOA gene test covered by insurance in India?
Genetic testing is not always covered by insurance. It is advisable to check with your insurance provider for specific coverage details.
Can this test be done during pregnancy?
Yes, genetic testing can be performed during pregnancy for prenatal diagnosis, but it should be done under medical supervision and genetic counseling.
What should I do if the test is positive for OTOA gene deafness?
A positive result confirms the diagnosis. Consult a genetic counselor or ENT specialist for management options, such as hearing aids, cochlear implants, and family planning advice.
Are there any risks associated with genetic testing for deafness?
Risks are minimal and mainly related to blood draw. However, genetic testing may have psychological implications or reveal variants of uncertain significance, requiring professional interpretation.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.